Jul 16, 2026 05:16PM
Jul 16, 2026 05:15PM
May 15, 2026 05:30AM
May 14, 2026 04:05PM
Oct 7, 2025 09:31AM
Jan 2, 2025 04:00PM
Aug 14, 2024 06:48AM H.C. Wainwright Reiterates Buy Rating on Jasper Therapeutics (JSPR)
Nov 9, 2023 08:00AM
Oct 9, 2023 08:02AM
Oct 9, 2023 08:00AM
Jun 13, 2023 08:01AM
Jun 13, 2023 08:00AM
Jan 10, 2023 08:07AM
Jan 10, 2023 08:00AM Jasper Therapeutics Announces Development Prioritization of Briquilimab in Chronic Diseases, Including Urticaria and Lower-Risk MDS, and Stem Cell Transplant for Sickle Cell Disease and Other Rare Dis
Jan 4, 2023 08:04AM
Jan 4, 2023 08:00AM
Nov 10, 2022 04:05PM
Nov 10, 2022 04:05PM
Sep 15, 2022 08:01AM
Sep 15, 2022 08:00AM
Aug 12, 2022 04:05PM Jasper Therapeutics Reports Second Quarter 2022 Financial Results and Provides a Corporate Update
May 12, 2022 04:05PM
May 12, 2022 04:05PM
Apr 28, 2022 08:03AM
Apr 28, 2022 08:00AM
Feb 24, 2022 05:20PM
Feb 24, 2022 05:19PM
Feb 24, 2022 05:19PM Jasper Therapeutics Announces JSP191 Phase 1b MDS/AML Late Breaking Data Presentation at the 2022 Transplantation & Cellular Therapy Tandem Meetings of ASTCT and CIBMTR
Nov 12, 2021 04:05PM
Nov 12, 2021 04:05PM
Oct 20, 2021 09:27AM
Oct 13, 2021 09:24AM
Oct 12, 2021 06:11PM

326,462 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All